1. Amneal Pharma launches Abiraterone Acetate tablets post USFDA nod
Amneal Pharmaceuticals announced that it has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application (ANDA), from the US Food and Drug Administration (FDA) for Abiraterone Acetate Tablets, USP, 250 mg and 500 mg.
2. Lupin gets USFDA nod for generic diabetes drug
Drug maker Lupin said it has received approval from the US health regulator for its Empagliflozin and Metformin Hydrochloride extended-release (ER) tablets, used to treat diabetes, in the American market.
